Skip to main content

Pravin Anand and Neeti Wilson look at the workings of intellectual property rights in the life sciences industry.

An in-depth look into the interaction between intellectual property rights and the protection of small molecules , particularly in the pharmaceutical sector, second-generation inventions, DNA, and biological and personalised medicine. The chapter also looks at the intricacies of compulsory licensing, patent infringement and enforcement.

Protection of patent also requires ascertaining ownership and compensation, and the ancillary IP involved in protecting branding and designs.

This chapter was published in IP in the Life Sciences.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
Thought Leadership
Feb 13, 2026

‘First published on Enterprise IT World’ By: Subroto Kumar Panda How the 2026 IT Rule Amendments Protect You in the Age of AI In an era where seeing

The Digital Armor – 2026
Thought Leadership
Feb 11, 2026

Authors: Safir Anand, Mudit Kaushik and Sehr Anand The establishment of a new National Institute of Design (NID-East) in India’s eastern region,

Can New NID-East Ignite India’s Design Revolution?
News & Updates, Thought Leadership
Feb 10, 2026

‘First published on India Business Law Journal’ By: Dr. Ajai Garg and Subroto Kumar Panda Business has always been about risk, the balance between

Agentic AI: Productivity gains, risks and data demands today
News & Updates, Thought Leadership
Jan 30, 2026

First published by Lexology. Authors: Safir Anand and Omesh Puri In today’s innovation‑driven economy, design rights have become a core element of

Proposed Reforms to India’s Design Protection Framework